Telcon RF Pharmaceutical Inc

Chart & Performance

D1W1MN

P/E

—

P/S

5.53

EPS

—

Div Yield, %

—

Shrs. gr., 5y

-4.35%

Rev. gr., 5y

5.43%

Revenues

43.16b

+13.99%

Net income

-11.46b

L-56.48%

CFO

1.67b

+36.73%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Profile

TELCON RF PHARMACEUTICAL. Inc. operates globally, specializing in the design, manufacturing, and sale of RF coaxial connectors. Their product offerings also encompass coaxial couplers, distributors, arresters, and various cable assemblies. The company, established in 1999, was previously known as Telcon Co., Ltd. and is headquartered in Yongin-si, South Korea.

URL

https://www.telcon.co.kr/

IPO date

Nov 24, 2014

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title KRW in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title KRW in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT